Multi-omics Analysis Reveals Mechanisms of FMT in Enhancing Antidepressant Effects of SSRIs

Published: 17 October 2024| Version 1 | DOI: 10.17632/bst5pyxdy2.1
Contributor:
Haohao Zhu

Description

Healthy male C57BL/6 mice were used to establish a depression model through chronic restraint stress, treated with fluoxetine, and categorized into Response and Non-response groups. An FMT treatment was added to the Non-response group. Behavioral tests were conducted to assess symptoms of depression. The gut microbiome, plasma metabolites, and hippocampal tissue gene expression and function changes were analyzed using 16S rRNA gene sequencing, LC-MS, and RNA sequencing.

Files not available for this dataset

This contains only metadata

Categories

Depression

Licence